Silver Sulfadiazine
From Anvita Health Wiki
Contents |
Introduction
- Tradename: Silvadene.
Indications
- prevention & treatment of infections in 2nd & 3rd degree burns
- wound dressing for pressure ulcers [4]
- malodorous wounds
- wounds with exudates
- suspected high bacterial load
- periwound inflammation
- slow healing wounds
Contraindications
- children < 2 months of age (sulfa drugs compete with bilirubin for protein- binding sites)
- Caution:
- pregnancy-category :value B)
- safety-in-lactation :value -
Dosage
- burns: 1% cream applied to thickness of 1/16 inch QD/ BID
- local anesthetic may be needed prior to application Cream (topical): 10 mg/g (1%) 20, 50, 85, 400, 1000 g.
- Also contains methylparaben & propylene glycol.
Pharmacokinetics
- up to 1% of silver is absorbed
- up to 10% of the sulfa component may be absorbed
Adverse-effects
- common (> 10%)
- less common (1-10%)
- itching, rash, erythema multiforme, skin discoloration, hemolytic anemia, leukopenia, agranulocytosis, aplastic anemia, hepatitis, pain, interstitial nephritis, allergic reactions*
- uncommon (< 1%)
- * allergic reactions may be related to sulfa component
Drug-interactions
- silver may inactivate topical proteolytic enzymes
- drug interaction(s) of antibiotics with warfarin
- silver may inactivate topical proteolytic enzymes
More General Terms
Internet Database
PubChem: 441244
PubChem: 452254
PubChem: 438204
PubChem: 31011
PubChem: 5214
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996.
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
- Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
